Latest News

At Adelphi Values PROVE we recognise that value demonstration for orphan/ ultra-orphan drugs in rare diseases requires a different focus to support successful market access. Read More

The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the Novartis-sponsored MSProDiscuss™ tool has now gone live on-line (https://msprodiscuss.com) and is available for MS clinicians to use.  This Clinician-Report discussion tool is available to help MS patients and physicians evaluate and… Read More

The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the FDA have qualified the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) as measures of the core symptoms of asthma in adults and adolescents. The FDA have highlighted that “these instruments have… Read More

We are delighted that one of our posters at ISPOR EU has been peer reviewed and nominated as an award finalist. The poster titled ‘Europe-wide spread of carbapenem-resistant bacteria: Epidemiology and disease burden’ provides an overview of antibiotic resistance, a critical global health issue which is becoming increasingly prevalent across Europe… Read More

The team at Adelphi Values | PROVE has been getting involved in environmentally-friendly initiatives in honour of World Earth Day which took place on Sunday 22nd April 2018. Read More

Each Christmas, instead of sending cards in the post, we at Adelphi Group provide our colleagues, partners and associates with the opportunity to nominate a worthy cause for us to donate to on their behalf.

In 2017, we supported Unicef to help make a difference for children all over the world. Read More

Adelphi Values applauds Revance Therapeutics in their demonstration of RT002 treatment success in their Pivotal SAKURA Phase 3 Trials for Glabellar Lines. Read More

Adelphi Values | PROVE will be leading a podium presentation entitled ‘Differences in vaccine pricing between high‑income and low‑income markets’. Read More

On Friday 28th July 2017 over 50 staff from the Adelphi Group took part in a 7 Peak Challenge – a marathon 26 mile walk through the Derbyshire and Cheshire hills located close to our UK head office.  Despite the torrential rain and strong winds, everyone was proud to take part in the 9-hour hike to help raise money for two wonderful causes, The Alzheimer’s Society and East Cheshire Hospice. Read More

Adelphi Values will be presenting and exhibiting at the 22nd Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 20th‑24th May 2017 in Boston, MA, USA. Read More

Our 2016 Adelphi Group Client Seasons Greetings charity initiative for Unicef received a fantastic response from our clients and partners, resulting in wonderful donations. Read More

Adelphi Values has been invited to present at the DIA’s Advancing the Science of Study Endpoints meeting to be held in Washington DC on Dec 5 and 6.  The purpose of the meeting is to assemble health outcomes experts to examine global strategies for selecting study endpoints and the impact… Read More

Meet our team presenting and exhibiting at the 19th Annual European Congress at ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 31st October to 2nd November 2016 in Vienna, Austria. Our workshop this year is entitled ‘Measuring multiple medication adherence – which… Read More

The Adelphi Group are one of the official sponsors of the 2016 Tour of Britain, the biggest cycling event in the UK.  This year, the event came to Cheshire, the location of our UK Global Headquarters. cheshiretourofbritain.co.uk/ Stuart Cooper, CEO of the Adelphi Group, was delighted to be… Read More

In October, our US team will be taking part in JDRF One Walk, to raise money for the Juvenile Diabetes Research Foundation (JDRF). Covering 5km around Boston, the JDRF flagship event aims to raise awareness of type1 diabetes (T1D), and funds toward achieving their mission, “to create a world without… Read More

The Institute of Pharmaceutical Medicine at the University of Basel invited Bryan Bennett from Adelphi Values to give a lecture to students of the post-graduate ‘European Course of Pharmaceutical Medicine’, a course which is typically undertaken by pharmaceutical industry professionals. The lecture titled ‘Epidemiology and patient-reported outcome studies’ was part… Read More

Thanks to all our clients and colleagues who visited our exhibition stand at ISPOR US which took place in Washington DC. As a result of your support, we have donated $500 to JDRF this year’s chosen charity. JDRF is a charitable organisation that supports sufferers and families… Read More

In June, our Boston team volunteered their time at one of the homeless shelters run by Heading Home , a non-profit organisation in Cambridge US. Heading Home provides emergency, transitional and permanent housing, as well as a variety of support services, to low-income homeless and formerly homeless families… Read More

Meet the team presenting and exhibiting at the 21st Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, taking place 23rd–25th May in Washington DC. Building on the success of previous ISPOR conferences, this year we will be hosting two workshops and presenting… Read More

We are honoured to have been invited to present at the 7th Annual Critical Path Institute Patient-Reported Outcome (PRO) Consortium Workshop to be held in Silver Spring, Maryland on 27th-28th April 2016. Rob Arbuckle, Managing Director of our UK Patient-Centered Outcomes practice, will be presenting two case studies as part… Read More